Fate Therapeutics
FATE
FATE
22 hedge funds and large institutions have $62.4M invested in Fate Therapeutics in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
33% less capital invested
Capital invested by funds: $92.8M → $62.4M (-$30.4M)
Holders
22
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$548K | |
| 2 | +$479K | |
| 3 | +$459K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$322K |
| 5 |
Goldman Sachs
New York
|
+$262K |
Top Sellers
| 1 | -$250K | |
| 2 | -$170K | |
| 3 | -$97K | |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$69.2K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$10K |